Repeat-associated non-AUG translation in C9orf72-ALS/FTD is driven by neuronal excitation and stress.

EMBO Mol Med

Department of Neuroscience, Jefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Jefferson University, Philadelphia, PA, USA

Published: February 2019

Nucleotide repeat expansions (NREs) are prevalent mutations in a multitude of neurodegenerative diseases. Repeat-associated non-AUG (RAN) translation of these repeat regions produces mono or dipeptides that contribute to the pathogenesis of these diseases. However, the mechanisms and drivers of RAN translation are not well understood. Here we analyzed whether different cellular stressors promote RAN translation of dipeptide repeats (DPRs) associated with the G4C2 hexanucleotide expansions in C9orf72, the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). We found that activating glutamate receptors or optogenetically increasing neuronal activity by repetitive trains of depolarization induced DPR formation in primary cortical neurons and patient derived spinal motor neurons. Increases in the integrated stress response (ISR) were concomitant with increased RAN translation of DPRs, both in neurons and different cell lines. Targeting phosphorylated-PERK and the phosphorylated-eif2α complex reduces DPR levels revealing a potential therapeutic strategy to attenuate DPR-dependent disease pathogenesis in NRE-linked diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365928PMC
http://dx.doi.org/10.15252/emmm.201809423DOI Listing

Publication Analysis

Top Keywords

repeat-associated non-aug
8
non-aug translation
8
translation
5
translation c9orf72-als/ftd
4
c9orf72-als/ftd driven
4
driven neuronal
4
neuronal excitation
4
excitation stress
4
stress nucleotide
4
nucleotide repeat
4

Similar Publications

Tandem repeat disorders: from diagnosis to emerging therapeutic strategies.

Encephalitis

December 2024

Rare Disease Center, Department of Genomic Medicine; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Article Synopsis
  • * These disorders present unique clinical features, such as reduced penetrance and changes in repeat motifs, and advancements in molecular diagnostics, especially long-read sequencing, have improved detection rates for TRDs.
  • * Innovative therapeutic approaches, including antisense oligonucleotides (ASOs) and gene editing technologies, show promise for treating these conditions, but further research is needed to enhance treatment efficacy and patient outcomes.
View Article and Find Full Text PDF

RuvBL1/2 reduce toxic dipeptide repeat protein burden in multiple models of C9orf72-ALS/FTD.

Life Sci Alliance

February 2025

Sheffield Institute for Translational Neuroscience (SITraN), Division of Neuroscience, School of Medicine and Population Health, Faculty of Health, University of Sheffield, Sheffield, UK

A G4C2 hexanucleotide repeat expansion in is the most common cause of amyotrophic lateral sclerosis and frontotemporal dementia (C9ALS/FTD). Bidirectional transcription and subsequent repeat-associated non-AUG (RAN) translation of sense and antisense transcripts leads to the formation of five dipeptide repeat (DPR) proteins. These DPRs are toxic in a wide range of cell and animal models.

View Article and Find Full Text PDF

Polyserine domains mediate the association of nuclear RNA binding proteins with cytoplasmic tau aggregates that occurs across tauopathy models and patient samples. In cell lines, polyserine peptides co-localize with and promote formation of tau aggregates suggesting the cytoplasmic mislocalization of polyserine-containing proteins might contribute to human disease. Moreover, polyserine can be produced by repeat associated non-AUG translation in CAG repeat expansion diseases.

View Article and Find Full Text PDF

A hexanucleotide GGGGCC repeat expansion in the non-coding region of the C9orf72 gene is the most common genetic mutation identified in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The resulting repeat RNA and dipeptide repeat proteins from non-conventional repeat translation have been recognized as important markers associated with the diseases. CRISPR/Cas13d, a powerful RNA-targeting tool, has faced challenges in effectively targeting RNA with stable secondary structures.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!